CUV 1.39% $14.20 clinuvel pharmaceuticals limited

The problem with the "tanning agent" approach is that the...

  1. 626 Posts.

    The problem with the "tanning agent" approach is that the medical authorities do not consider sunburn or fair skin to be a disease. For a drug to get approval it has to treat a recognised disease. Hence CUV are looking to get the drug approved for sun allergy (a recognised disease). Once the drug is approved then a doctor can prescribe it to treat whatever he wants (including sunburn, skin cancer, fair skin etc).

    I think Botox took this route as well - it was approved for a particular disease and then plastic surgeons were able to use it for beauty treatments - unfortunately, wrinkles are not recognised as a disease either.

    Spartz.
 
watchlist Created with Sketch. Add CUV (ASX) to my watchlist
(20min delay)
Last
$14.20
Change
-0.200(1.39%)
Mkt cap ! $710.8M
Open High Low Value Volume
$14.35 $14.60 $13.87 $1.831M 129.8K

Buyers (Bids)

No. Vol. Price($)
1 31 $14.15
 

Sellers (Offers)

Price($) Vol. No.
$14.20 317 1
View Market Depth
Last trade - 16.10pm 31/10/2024 (20 minute delay) ?
CUV (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.